MoneyWorks4Me

Dr.Reddy's Laboratories informs about disclosure

17 Jun 2023 Evaluate
Dr.Reddy's Laboratories has informed regarding completion of GMP inspection by USFDA of its API facility at Bollaram (CTO3) with zero observations and receipt of EIR for closure of the USFDA inspection conducted at FTO SEZ PU2.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1153.45
Cipla 1358.00
Lupin 2073.00
Zydus Lifesciences 1111.70
View more..